RediNews
ETFs Holding ABBV »    ABBV Historical Stock Prices »
ABBV News Video: Thu, Sep 28, 2017, 10:48 AM — XLF, RNDV: Big ETF Inflows


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
AbbVie is a research-based biopharmaceutical company. Co.'s portfolio of products includes a line of therapies that addresses serious diseases such as: HUMIRA (adalimumab) to treat autoimmune diseases; oncology products such as IMBRUVICA (ibrutinib) and Venclexta (venetoclax); virology products such as VIEKIRA PAK for the treatment of hepatitis C and Norvir (ritonavir) for the treatment of human immunodeficiency virus-1 infection; metabolic and hormone products that target conditions such as testosterone deficiency; endocrinology products such as Lupron (leuprolide acetate) for the palliative treatment of advanced prostate cancer, treatment of endometriosis and central precocious puberty. Self directed investors in AbbVie will be interested in keeping up with all AbbVie news they can find, both ABBV news originating from the company in the form of press releases, as well as seeing how independent media outlets are reporting news on ABBV. At RediNews, we simplify this task by presenting both ABBV news releases originating from AbbVie itself, and ABBV news from a variety of media outlets. Visitors can browse this news online and through our ABBV RSS news feed.

AbbVie News

AbbVie News — Articles, Videos, & Press Releases

Noteworthy Friday Option Activity: UAL, GILD, ABBV
Friday, December 8, 2017, 2:13 PM — Stock Options Channel
VTI, CMCSA, BA, ABBV: ETF Inflow Alert
Thursday, December 7, 2017, 11:08 AM — ETF Channel
AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan
Wednesday, December 6, 2017, 7:52 AM — Zacks
AbbVie Psoriasis Candidate Succeeds in 4th Phase III Study
Tuesday, December 5, 2017, 8:52 AM — Zacks
Lilly's (LLY) Taltz Gets Approval for Label Expansion in US
Monday, December 4, 2017, 8:11 AM — Zacks
3 Drug/Biotech Stocks in Focus on World AIDS Day
Friday, December 1, 2017, 4:58 PM — Zacks
Notable Thursday Option Activity: MA, ABBV, ADP
Thursday, November 30, 2017, 3:23 PM — Stock Options Channel
AbbVie Stock Up More Than 30% So Far in 2H17: Here's Why
Thursday, November 30, 2017, 9:17 AM — Zacks
iShares Russell Top 200 Growth ETF Experiences Big Outflow
Wednesday, November 29, 2017, 10:49 AM — ETF Channel
J&J & Glaxo's Jucala Approval Puts Spotlight on HIV Space
Friday, November 24, 2017, 1:11 PM — Zacks
3 Companies Competing to Gain Lead in Ovarian Cancer Market
Friday, November 24, 2017, 10:24 AM — Zacks
Galapagos' CF Candidate Shows Potential in Phase II Study
Monday, November 20, 2017, 8:44 AM — Zacks
Amgen (AMGN) Unveils Auto Injector Device for Enbrel in US
Monday, November 20, 2017, 8:30 AM — Zacks
Notable ETF Inflow Detected - XLV, JNJ, PFE, ABBV
Friday, November 17, 2017, 10:47 AM — ETF Channel
Roche's (RHHBY) Hemophilia A Drug Receives FDA Approval
Friday, November 17, 2017, 8:05 AM — Zacks
Biotechs Trading Lower in Q4 on Macro Uncertainty, Tepid Q3
Friday, November 17, 2017, 6:09 AM — Zacks
Novartis (NVS) Arm's Biosimilars Study Results Encourage
Tuesday, November 14, 2017, 7:31 AM — Zacks
Arena (ARNA) Completes Enrolment in Etrasimod Phase II Study
Monday, November 13, 2017, 8:44 AM — Zacks
Amgen Gets Positive CHMP Opinion to Expand Nplate's Label
Monday, November 13, 2017, 7:57 AM — Zacks
XLV, MRK, ABBV, AMGN: ETF Outflow Alert
Thursday, November 9, 2017, 11:10 AM — ETF Channel
iShares Russell 1000 Growth ETF Experiences Big Inflow
Tuesday, October 31, 2017, 10:57 AM — ETF Channel
HCA Healthcare (HCA) Posts In-Line Q3 Earnings, Keeps View
Tuesday, October 31, 2017, 8:40 AM — Zacks
AbbVie (ABBV) Q3 Earnings Top, Revenues In Line, View Up
Friday, October 27, 2017, 10:15 AM — Zacks
Data and Earnings Deluge
Friday, October 27, 2017, 8:42 AM — Zacks
Q3 GDP Hits 3.0%, Q3 Earnings Take Pre-Market Higher
Friday, October 27, 2017, 8:27 AM — Zacks
Gilead (GILD) Down on Weak HCV Sales Despite Q3 Earnings Beat
Friday, October 27, 2017, 7:58 AM — Zacks
AbbVie (ABBV) Q3 Earnings Surpass Estimates, Guidance Raised
Friday, October 27, 2017, 6:13 AM — Zacks
Notable Thursday Option Activity: PX, ABBV, DMRC
Thursday, October 26, 2017, 3:21 PM — Stock Options Channel
Must-Watch Earnings Charts to End the Week
Thursday, October 26, 2017, 1:51 PM — Zacks
Vertex (VRTX) Beats on Q3 Earnings & Sales, Raises 2017 View
Thursday, October 26, 2017, 9:51 AM — Zacks
Bristol-Myers (BMY) Misses on Q3 Earnings, Opdivo in Focus
Thursday, October 26, 2017, 9:41 AM — Zacks
Key Predictions for Q3 Earnings Reports of ABBV, MRK
Thursday, October 26, 2017, 8:06 AM — Zacks
Biogen (BIIB) Tops Q3 Earnings & Sales, Spinraza Sales Up
Tuesday, October 24, 2017, 10:53 AM — Zacks
Can AbbVie (ABBV) Spring a Surprise this Earnings Season?
Tuesday, October 24, 2017, 8:35 AM — Zacks
Notable ETF Inflow Detected - VHT, ABBV, AGN, DHR
Monday, October 23, 2017, 11:18 AM — ETF Channel
Is Gilead (GILD) Poised for a Beat This Earnings Season?
Monday, October 23, 2017, 8:03 AM — Zacks
Abbvie Inks Immuno-Oncology Deal with Harpoon Therapeutics
Friday, October 20, 2017, 3:36 PM — Zacks
Cancer Treatment Update: Second Gene Therapy Receives Approval
Friday, October 20, 2017, 3:28 PM — Zacks
Notable Wednesday Option Activity: AGN, REGN, ABBV
Wednesday, October 18, 2017, 2:24 PM — Stock Options Channel
What's in the Cards for Novartis (NVS) This Earnings Season?
Wednesday, October 18, 2017, 4:36 AM — Zacks
Where to Find Value in Healthcare Stocks
Tuesday, October 17, 2017, 5:33 PM — Zacks
Sanofi/Regeneron's Dupixent Succeeds in Phase II Study
Tuesday, October 17, 2017, 8:48 AM — Zacks
J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales
Tuesday, October 17, 2017, 8:37 AM — Zacks
January 2020 Options Now Available For AbbVie
Monday, October 16, 2017, 11:29 AM — Stock Options Channel
J&J's Psoriasis Drug Stelara Gets FDA Nod for Adolescent Use
Monday, October 16, 2017, 7:38 AM — Zacks
IUSG, HD, ABBV, MA: ETF Inflow Alert
Friday, October 13, 2017, 11:05 AM — ETF Channel
Spin-Off ETF: Can the Outperformance Continue?
Friday, October 13, 2017, 10:20 AM — Zacks
Cancer Space Update: Lung & Breast Cancer Studies in Focus
Friday, October 13, 2017, 9:18 AM — Zacks
AbbVie Reaches Analyst Target Price
Thursday, October 12, 2017, 9:01 AM — ETF Channel
Is the Options Market Predicting a Spike in AbbVie (ABBV) Stock?
Thursday, October 12, 2017, 6:48 AM — Zacks
Allergan's Uterine Fibroids Candidate's NDA Accepted by FDA
Wednesday, October 11, 2017, 1:34 PM — Zacks
Notable Wednesday Option Activity: ABBV, AGN, REGN
Wednesday, October 11, 2017, 1:33 PM — Stock Options Channel
Ex-Dividend Reminder: Foot Locker, Patterson Companies and AbbVie
Tuesday, October 10, 2017, 9:57 AM — Dividend Channel
Here's What's Has Happened in the HCV Space Lately
Friday, October 6, 2017, 2:10 PM — Zacks
AbbVie (ABBV) Stock Up Almost 17% in One Month: Here's Why
Thursday, October 5, 2017, 8:32 AM — Zacks
IYY, ABBV, MMM, HON: Large Outflows Detected at ETF
Wednesday, October 4, 2017, 10:47 AM — ETF Channel
Merck Drops Two HCV Combination Programs Amid Competition
Monday, October 2, 2017, 6:40 AM — Zacks
Noteworthy Thursday Option Activity: VLO, ABBV, ABT
Thursday, September 28, 2017, 1:22 PM — Stock Options Channel
Gilead (GILD) Gets Approval for HCV Drug Sovaldi in China
Thursday, September 28, 2017, 7:10 AM — Zacks
Alliant Energy Becomes #192 Most Shorted S&P 500 Component, Replacing AbbVie
Wednesday, September 27, 2017, 2:48 PM — Market News Video
ABBV Dividend Yield Pushes Past 3%
Tuesday, September 26, 2017, 3:24 PM — Dividend Channel
Notable ETF Inflow Detected - ITOT, DWDP, ABBV, MMM
Tuesday, September 26, 2017, 11:01 AM — ETF Channel
Abbvie/Bristol-Myers Inks Deal to Develop Therapeutic Cancer
Monday, September 25, 2017, 8:49 AM — Zacks
Gilead's (GILD) Epclusa Receives Label Expansion in Canada
Friday, September 22, 2017, 1:14 PM — Zacks
Roche (RHHBY) Announces Positive Data on Leukemia Drug
Tuesday, September 19, 2017, 1:14 PM — Zacks
AbbVie Named Top Dividend Stock With Insider Buying and 3.01% Yield (ABBV)
Tuesday, September 19, 2017, 11:12 AM — Dividend Channel
WisdomTree U.S. Quality Dividend Growth Fund Experiences Big Inflow
Monday, September 18, 2017, 11:04 AM — ETF Channel
J&J's (JNJ) Psoriasis Drug Guselkumab Gets CHMP Nod in EU
Monday, September 18, 2017, 8:15 AM — Zacks
Notable Friday Option Activity: ABBV, UAA, HOME
Friday, September 15, 2017, 3:24 PM — Stock Options Channel
Friday Sector Laggards: Healthcare, Utilities
Friday, September 15, 2017, 2:34 PM — Market News Video
Novartis Announces Long-Term Data on Psoriasis Drug Cosentyx
Thursday, September 14, 2017, 9:00 AM — Zacks
Newell Brands Becomes #164 Most Shorted S&P 500 Component, Replacing AbbVie
Wednesday, September 13, 2017, 1:23 PM — Market News Video
AbbVie's RA Candidate Meets Primary Endpoint in Phase III
Tuesday, September 12, 2017, 8:59 AM — Zacks
AbbVie a Top Ranked SAFE Dividend Stock With 3.0% Yield (ABBV)
Monday, September 11, 2017, 7:40 AM — ETF Channel
Friday Sector Leaders: Financial, Healthcare
Friday, September 8, 2017, 3:12 PM — Market News Video
Notable Friday Option Activity: XL, ABBV, COST
Friday, September 8, 2017, 1:28 PM — Stock Options Channel
ABBV Crosses Above Average Analyst Target
Friday, September 8, 2017, 9:21 AM — ETF Channel
Thursday Sector Leaders: Healthcare, Utilities
Thursday, September 7, 2017, 2:34 PM — Market News Video
Vanguard High Dividend Yield ETF Experiences Big Inflow
Thursday, September 7, 2017, 10:54 AM — ETF Channel
AbbVie Submits NDA for Endometriosis Candidate to the FDA
Thursday, September 7, 2017, 8:45 AM — Zacks
Forget Abbott, Buy These 4 High-Growth MedTech Stocks Instead
Wednesday, September 6, 2017, 10:30 AM — Zacks
4 Drug Stocks Worth a Look on Promising Cancer Pipeline
Wednesday, September 6, 2017, 8:11 AM — Zacks
Gilead to Fly High with Kite Pharma Acquisition for $11.9B
Tuesday, August 29, 2017, 2:51 PM — Zacks
Noteworthy ETF Inflows: IUSG, MA, MO, ABBV
Tuesday, August 29, 2017, 10:53 AM — ETF Channel
Roche's Gazyva Gets Priority Review for Follicular Lymphoma
Monday, August 28, 2017, 5:19 PM — Zacks
AbbVie Becomes #164 Most Shorted S&P 500 Component, Replacing Moody's Corp.
Friday, August 25, 2017, 2:43 PM — Market News Video
Biogen's Humira Biosimilar Imraldi Gets Approval in EU
Friday, August 25, 2017, 9:13 AM — Zacks
Roche (RHHBY) Hemophilia A Drug Granted Priority Review
Thursday, August 24, 2017, 8:08 AM — Zacks
AbbVie Now #41 Largest Company, Surpassing Medtronic
Wednesday, August 23, 2017, 4:44 PM — Market News Video
iShares Russell 1000 Growth ETF Experiences Big Outflow
Monday, August 21, 2017, 11:12 AM — ETF Channel
RNDV's Underlying Holdings Could Mean 12% Gain Potential
Monday, August 21, 2017, 8:38 AM — ETF Channel
AbbVie's HCV Combo Drug Mavyret Clinches Approval in Canada
Friday, August 18, 2017, 8:32 AM — Zacks
Gilead (GILD) HCV Drug Vosevi Receives Approval in Canada
Friday, August 18, 2017, 8:10 AM — Zacks
Gilead (GILD) NDA for HIV Combo Regimen Gets Priority Review
Monday, August 14, 2017, 7:44 AM — Zacks
IWF, ABBV, CELG, AVGO: Large Outflows Detected at ETF
Friday, August 11, 2017, 10:46 AM — ETF Channel
The New #166 Most Shorted S&P 500 Component: ONEOK
Thursday, August 10, 2017, 3:25 PM — Market News Video
AbbVie Inc a Top 25 Dividend Giant With 3.56% Yield (ABBV)
Thursday, August 10, 2017, 9:55 AM — ETF Channel
Infinity (INFI) Q2 Loss Wider than Expected, View Intact
Friday, August 4, 2017, 2:29 PM — Zacks
Momenta (MNTA) Q2 Loss In Line with Estimates, Sales Beat
Thursday, August 3, 2017, 3:04 PM — Zacks
Top Buys by Directors: Rapp's $281.8K Bet on ABBV
Thursday, August 3, 2017, 2:13 PM — Dividend Channel
Noteworthy ETF Outflows: VYM, PFE, MMM, ABBV
Tuesday, August 1, 2017, 11:53 AM — ETF Channel
Key FDA Events to Watch Out for in Aug 2017
Tuesday, August 1, 2017, 5:29 AM — Zacks
Drug Stocks Q2 Earnings Releases on Aug 1: PFE, AERI & INCY
Monday, July 31, 2017, 8:30 AM — Zacks
Notable Friday Option Activity: MA, ABBV, APA
Friday, July 28, 2017, 2:27 PM — Stock Options Channel
AbbVie (ABBV) Tops Q2 Earnings & Revenues, Outlook Intact
Friday, July 28, 2017, 1:20 PM — Zacks
AbbVie (ABBV) Tops Q2 Earnings and Revenue
Friday, July 28, 2017, 6:13 AM — Zacks
Friday's Earnings Reports To Watch: XOM, CVX, MRK, ABBV
Thursday, July 27, 2017, 2:34 PM — Zacks
Pharma Stocks to Watch for Earnings on Jul 28: ABBV, MRK
Thursday, July 27, 2017, 8:42 AM — Zacks
Vertex (VRTX) Q2 Earnings Top on Solid Cystic Fibrosis Sales
Thursday, July 27, 2017, 6:59 AM — Zacks
Gilead (GILD) Tops Q2 Earnings& Revenue Estimates, Stock Up
Thursday, July 27, 2017, 6:00 AM — Zacks
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, July 26, 2017, 8:50 AM — ETF Channel
Biogen (BIIB) Tops Q2 Earnings & Sales, Spinraza Sales Up
Tuesday, July 25, 2017, 12:37 PM — Zacks
Noteworthy ETF Inflows: VYM, PFE, MMM, ABBV
Monday, July 24, 2017, 10:53 AM — ETF Channel
Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs
Monday, July 24, 2017, 8:11 AM — Zacks
AbbVie Inc's. (ABBV) Q2 Earnings: Disappointment in Store?
Friday, July 21, 2017, 2:22 PM — Zacks
Is Gilead (GILD) Poised for a Beat This Earnings Season?
Thursday, July 20, 2017, 6:30 AM — Zacks
Gilead's HCV Portfolio Receives a Boost With Vosevi Approval
Wednesday, July 19, 2017, 8:15 AM — Zacks
Can Biogen (BIIB) Keep the Earnings Streak Alive in Q2?
Wednesday, July 19, 2017, 7:52 AM — Zacks
Perrigo Company Gets FDA Approval for Generic Topical Gel
Tuesday, July 18, 2017, 4:12 PM — Zacks
Repros' Proellex Stays on Partial Clinical Hold, Shares Fall
Tuesday, July 18, 2017, 3:50 PM — Zacks
Notable ETF Inflow Detected - VHT, PFE, MDT, ABBV
Friday, July 14, 2017, 10:52 AM — ETF Channel
J&J (JNJ) Gets FDA Nod for Psoriasis Drug -- Guselkumab
Friday, July 14, 2017, 8:22 AM — Zacks
Can Novartis (NVS) Spring a Surprise This Earnings Season?
Friday, July 14, 2017, 6:18 AM — Zacks
CME Group Becomes #137 Most Shorted S&P 500 Component, Replacing AbbVie
Thursday, July 13, 2017, 2:52 PM — Market News Video
Amgen Gets FDA Nod to Broaden Leukemia Drug Blincyto's Label
Wednesday, July 12, 2017, 8:05 AM — Zacks
IPO Market Back On Track: ETFs to Tap
Wednesday, July 12, 2017, 7:50 AM — Zacks
Noteworthy Tuesday Option Activity: PH, YELP, ABBV
Tuesday, July 11, 2017, 3:36 PM — Stock Options Channel
Roche (RHHBY) Announces Positive Data on Hemophilia A Drug
Tuesday, July 11, 2017, 3:32 PM — Zacks
Ex-Dividend Reminder: Patterson Companies, AbbVie and Abbott Laboratories
Monday, July 10, 2017, 10:00 AM — Dividend Channel
Novartis' Cosentyx Superior to Stelara in Psoriasis Study
Monday, July 10, 2017, 9:12 AM — Zacks
Bristol-Myers Gets FDA Nod for Orencia's Label Expansion
Friday, July 7, 2017, 7:16 AM — Zacks
Galapagos-Gilead Begin Phase II Study on Uveitis Candidate
Wednesday, July 5, 2017, 2:57 PM — Zacks
Vanguard High Dividend Yield ETF Experiences Big Outflow
Wednesday, July 5, 2017, 10:52 AM — ETF Channel
Bayer Starts Phase III Study for Uterine Fibroids' Candidate
Tuesday, July 4, 2017, 6:25 AM — Zacks
Roche's (RHHBY) Leukemia Drug Gets Prime Status in EU
Friday, June 30, 2017, 8:07 AM — Zacks
Target Becomes #125 Most Shorted S&P 500 Component, Replacing AbbVie
Tuesday, June 27, 2017, 2:41 PM — Market News Video
Health Care Select Sector SPDR Fund Experiences Big Inflow
Tuesday, June 27, 2017, 11:44 AM — ETF Channel
Gilead's (GILD) HCV Drug Application Accepted in the EU
Tuesday, June 27, 2017, 8:03 AM — Zacks
Bristol-Myers Reports Data on Immuno-Oncology Drug Empliciti
Tuesday, June 27, 2017, 8:01 AM — Zacks
AbbVie's HCV Combo Drug Gets Positive CHMP Opinion in EU
Tuesday, June 27, 2017, 7:58 AM — Zacks
Noteworthy Thursday Option Activity: COST, ABBV, AET
Thursday, June 22, 2017, 2:33 PM — Stock Options Channel
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, June 21, 2017, 9:12 AM — ETF Channel
Commit To Purchase AbbVie At $40, Earn 2.5% Using Options
Tuesday, June 20, 2017, 11:34 AM — Stock Options Channel
J&J-AbbVie's Imbruvica Positive in Follow-up Lymphoma Study
Tuesday, June 20, 2017, 9:28 AM — Zacks
Health Care Select Sector SPDR Fund Experiences Big Inflow
Monday, June 19, 2017, 10:55 AM — ETF Channel
AbbVie (ABBV) Stock Hits 52-Week High: More Room to Run?
Monday, June 19, 2017, 8:28 AM — Zacks
Novartis (NVS) Announced Positive Data on Psoriasis Cosentyx
Thursday, June 15, 2017, 3:38 PM — Zacks
AbbVie a Top Socially Responsible Dividend Stock With 3.6% Yield (ABBV)
Thursday, June 15, 2017, 7:22 AM — ETF Channel
PowerShares Dynamic Pharmaceuticals Portfolio Experiences Big Outflow
Friday, June 9, 2017, 10:45 AM — ETF Channel
AbbVie (ABBV) Announced Positive Phase III RA Candidate Data
Thursday, June 8, 2017, 8:10 AM — Zacks
Notable ETF Inflow Detected - VOO, BRK.B, V, ABBV
Thursday, June 1, 2017, 10:51 AM — ETF Channel
Novartis Biosimilar Pipeline, 2018 Growth Plans on Track
Wednesday, May 31, 2017, 3:30 PM — Zacks
Biogen's Fampyra Conditional Approval Converted to Standard
Thursday, May 25, 2017, 7:16 AM — Zacks
Notable Thursday Option Activity: ABBV, LB, GPS
Thursday, May 18, 2017, 1:34 PM — Stock Options Channel
SPHD's Holdings Imply 10% Gain Potential
Thursday, May 18, 2017, 9:06 AM — ETF Channel
AbbVie Down on Humira Patent Loss: Is More Damage in Store?
Thursday, May 18, 2017, 7:23 AM — Zacks
Celgene's (CELG) Revlimid Looks Solid on Label Expansion
Tuesday, May 16, 2017, 4:14 PM — Zacks
AbbVie and J&J Present Positive Imbruvica Leukemia Data
Monday, May 15, 2017, 8:30 AM — Zacks
Noteworthy ETF Inflows: DGRO, ABBV, MCD, MDT
Friday, May 12, 2017, 10:50 AM — ETF Channel
Notable Wednesday Option Activity: KORS, ABBV, LNG
Wednesday, May 10, 2017, 3:32 PM — Stock Options Channel
Infinity (INFI) Reports Narrower-than-Expected Loss in Q1
Wednesday, May 10, 2017, 7:58 AM — Zacks
iShares Core Dividend Growth ETF Experiences Big Inflow
Thursday, May 4, 2017, 10:46 AM — ETF Channel
Gilead (GILD) Beats on Q1 Earnings, Revenues Miss Estimates
Wednesday, May 3, 2017, 8:25 AM — Zacks
Drug Stocks Q1 Earnings Slated for May 2: MRK, PFE & GILD
Monday, May 1, 2017, 7:40 AM — Zacks
AbbVie (ABBV) Q1 Earnings Beat Estimates, Revenues Up Y/Y
Thursday, April 27, 2017, 2:52 PM — Zacks
AbbVie (ABBV) Beats Earnings and Revenue in Q1
Thursday, April 27, 2017, 7:27 AM — Zacks
5 Fantastic Earnings Charts
Wednesday, April 26, 2017, 2:06 PM — Zacks
UPRO, MDT, MCD, ABBV: Large Outflows Detected at ETF
Wednesday, April 26, 2017, 10:50 AM — ETF Channel
Pharma Stocks Q1 Earnings Roster for Apr 27: CELG, ABBV, BMY
Wednesday, April 26, 2017, 6:04 AM — Zacks
Gilead (GILD) Q1 Earnings: Stock Likely to Beat Estimates?
Tuesday, April 25, 2017, 2:00 PM — Zacks
Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong
Tuesday, April 25, 2017, 8:46 AM — Zacks
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1?
Monday, April 24, 2017, 8:06 AM — Zacks
AbbVie (ABBV) Presents Positive Data on HCV Combination Drug
Friday, April 21, 2017, 9:25 AM — Zacks
What's in Store for AbbVie (ABBV) this Earnings Season?
Friday, April 21, 2017, 7:57 AM — Zacks
Noteworthy Thursday Option Activity: NRZ, ILMN, ABBV
Thursday, April 20, 2017, 3:29 PM — Stock Options Channel
What's in Store for Biogen (BIIB) this Earnings Season?
Thursday, April 20, 2017, 8:16 AM — Zacks
AbbVie's (ABBV) Cancer Candidate Fails in Phase III Studies
Thursday, April 20, 2017, 7:53 AM — Zacks
5 Dividend Growth Stocks With Upside To Analyst Targets
Wednesday, April 19, 2017, 8:31 AM — ETF Channel
ABBV is categorized under the Healthcare sector; below are links to news for some other companies in the same sector:

BDSI News
CYH News
USPH News
THRX News
IPCM News
HALO News
NKTR News
SPPI News
EXEL News
HSP News

RediNews invites those seeking web page financial content for any internet portal, especially any vertical portal specializing in the markets where there is a web page for business, web page for markets, web page finance, etc., to integrate our free web site content, our RSS news feeds. These RSS feeds are found throughout our website wherever news and custom stock content is found, by clicking the RSS icon for any news page (which will look like this): . This dynamic financial content is ideal for sites that already feature stock data content such as historical stock price information whether in the form of a historical stock price table or a web page chart image, to supplement the other custom stock market content displayed.

AbbVie News | www.RediNews.com | Copyright © 2013 - 2017, All Rights Reserved

Nothing in www.RediNews.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.